Abstract:To determine chemical-protein interactions (CPI) is costly, time-consuming, and labor-intensive. In silico prediction of CPI can facilitate the target identification and drug discovery. Although many in silico target prediction tools have been developed, few of them could predict active molecules against multitarget for a single disease. In this investigation, naive Bayesian (NB) and recursive partitioning (RP) algorithms were applied to construct classifiers for predicting the active molecules against 25 key targets toward Alzheimer's disease (AD) using the multitarget-quantitative structure-activity relationships (mt-QSAR) method. Each molecule was initially represented with two kinds of fingerprint descriptors (ECFP6 and MACCS). One hundred classifiers were constructed, and their performance was evaluated and verified with internally 5-fold cross-validation and external test set validation. The range of the area under the receiver operating characteristic curve (ROC) for the test sets was from 0.741 to 1.0, with an average of 0.965. In addition, the important fragments for multitarget against AD given by NB classifiers were also analyzed. Finally, the validated models were employed to systematically predict the potential targets for six approved anti-AD drugs and 19 known active compounds related to AD. The prediction results were confirmed by reported bioactivity data and our in vitro experimental validation, resulting in several multitarget-directed ligands (MTDLs) against AD, including seven acetylcholinesterase (AChE) inhibitors ranging from 0.442 to 72.26 μM and four histamine receptor 3 (H3R) antagonists ranging from 0.308 to 58.6 μM. To be exciting, the best MTDL DL0410 was identified as an dual cholinesterase inhibitor with IC50 values of 0.442 μM (AChE) and 3.57 μM (BuChE) as well as a H3R antagonist with an IC50 of 0.308 μM. This investigation is the first report using mt-QASR approach to predict chemical-protein interaction for a single disease and discovering highly potent MTDLs. This protocol may be useful for in silico multitarget prediction of other diseases.

MT-EpiPred: Multitask Learning for Prediction of Small-Molecule Epigenetic Modulators

Case-Based Meta-Prediction for Bioinformatics.

MSPEDTI: Prediction of Drug–Target Interactions via Molecular Structure with Protein Evolutionary Information

EMUDRA: Ensemble of Multiple Drug Repositioning Approaches to improve prediction accuracy.

MetaHMEI: meta-learning for prediction of few-shot histone modifying enzyme inhibitors

PmxPred: A data-driven approach for the identification of active polymyxin analogues against gram-negative bacteria

The Development and Application of KinomePro-DL: A Deep Learning Based Online Small Molecule Kinome Selectivity Profiling Prediction Platform

MATE-Pred: Multimodal Attention-based TCR-Epitope interaction Predictor

Discovery of Multitarget-Directed Ligands Against Alzheimer'S Disease Through Systematic Prediction of Chemical Protein Interactions

MDTips: A Multimodal-data based Drug-Target interaction prediction system fusing knowledge, gene expression profile and structural data

AMGC is a Multiple-Task Graph Neutral Network for Epigenetic Target Profiling

Development of Machine Learning Models for Accurately Predicting and Ranking the Activity of Lead Molecules to Inhibit PRC2 Dependent Cancer

Prediction of drug efficacy from transcriptional profiles with deep learning

A Computational Approach for the Discovery of Novel DNA Methyltransferase Inhibitors

CODD-Pred: A Web Server for Efficient Target Identification and Bioactivity Prediction of Small Molecules

In-silico Target Prediction by Ensemble Chemogenomic Model Based on Multi-Scale Information of Chemical Structures and Protein Sequences.

MDeePred: novel multi-channel protein featurization for deep learning-based binding affinity prediction in drug discovery

KinomeMETA: a web platform for kinome-wide polypharmacology profiling with meta-learning

Accurate Prediction of Lysine Methylation Sites Using Evolutionary and Structural-Based Information

Single-cell profiling of small molecule-genomic interactions and epigenetic states

Delta.EPI: a probabilistic voting-based enhancer–promoter interaction prediction platform